Panacea to make 25 million doses of Sputnik vaccine

By: |
August 06, 2021 5:15 AM

As per the agreement, Panacea would produce Sputnik V vaccine using the ready to fill drug substance manufactured by Generium in Russia and then supply the entire quantity to Dr Reddy's for distribution in India, the company said in a regulatory filing on the BSE.

The Sputnik V vaccine has already received emergency usage authorisation in India.The Sputnik V vaccine has already received emergency usage authorisation in India.

Pharma and biotech company Panacea Biotec said on Thursday that the firm had entered into a licensing and manufacturing agreement with Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories to manufacture 25 million doses of Sputnik V vaccine.

Panacea signed the agreement with Human Vaccine Limited Liability Company (a subsidiary of RDIF), Generium Joint Stock Company and Dr Reddy’s to produce the Sputnik vaccine. As per the agreement, Panacea would produce Sputnik V vaccine using the ready to fill drug substance manufactured by Generium in Russia and then supply the entire quantity to Dr Reddy’s for distribution in India, the company said in a regulatory filing on the BSE.

The Sputnik V vaccine has already received emergency usage authorisation in India.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Over 2.09 lakh people given COVID-19 vaccine in Delhi
2AstraZeneca Pharma India gets DCGI nod to import, market Selumetinib capsules
3US has enough COVID-19 vaccines for boosters, kids’ shots